Experimental and Clinical Psychopharmacology ® invites you to submit a high-quality paper that advances the translational and interdisciplinary research on psychopharmacology and drug abuse. The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, brain imaging, genetics, neuroendocrinology, neuroscience, and pharmacology.
Submitted papers that involve the following are given preference:
One goal of the journal is to encourage increased attention to biologic factors that may influence both the pharmacodynamicand the pharmacokinetic effects of drugs. Recent research has shown the importance of examining the effects of sex and menstrual/estrous cycle phase on the effects of abused drugs, as well as responses to medications for the treatment of drug abuse and the alleviation of pain.
The journal publishes original reports on the development and evaluation of new pharmacotherapies, the influence of genetics and hormones on responses to abused drugs and treatment medications, the pharmacological management of pain, and brain imaging studies of the neural correlates of drug effects.The journal will focus on clinical laboratory studies and controlled clinical medication trials as well as basic preclinical experiments on psychopharmacology, including substance use and related disorders.
Manuscripts should be submitted electronically through the Experimental and Clinical Psychopharmacology submission portal.
Authors must indicate in their cover letter that their paper should be considered for this call for papers. All submissions will undergo peer-review.
We look forward to your submission. For questions or further information please contact the Editor, Suzette Evans.
Sent from my iPhone